[1] Xu RA, Barker MF. Annual changes in the steroid levels in the ovaries and the pyloric caeca of Sclerasterias mollis(Echinodermata: Asteroidea) during the reproductive cycle[J]. Comp Biochem Physiol A Physiol, 1990, 95(1): 127-133.
[2] Straub RH. The complex role of estrogens in inflammation[J]. Endocr Rev, 2007, 28(5): 521-574.
[3] Hirano S, Furutama D, Hanafusa T. Physiologically high concentrations of 17β-estradiol enhance NF-κB activity in human T cells[J]. Am J Physiol Regul Integr Comp Physiol, 2007, 292(4): R1465-1471.
[4] Lelu K, Delpy L, Robert V, et al. Endogenous estrogens, through estrogen receptor alpha, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS[J]. Eur J Immunol, 2010, 40(12): 3489-3498.
[5] Suzuki T, Shimizu T, Yu HP, et al. Salutary effects of 17β-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-α[J]. Am J Physiol Cell Physiol, 2007, 292(6): C2103-2111.
[6] Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production[J]. Curr Drug Targets Inflamm Allergy, 2004, 3(1): 97-104.
[7] Karpuzoglu E, Fenaux JB, Phillips RA, et al. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon- {gamma}[J]. Endocrinology, 2006, 147(2): 662-671.
[8] Hong M, Zhu Q. Macrophages are activated by 17b-estradiol: possible permission role in endometriosis [J]. Exp Toxicol Pathol, 2004, 55(5): 385-391.
[9] Azenabor AA, Yang S, Job G, et al. Expression of iNOS gene in macrophages stimulated with 17β-estradiol is regulated by free intracellular Ca2+[J]. Biochem Cell Biol, 2004, 82(3): 381-390.
[10] Gragasin FS, Xu Y, Arenas IA, et al. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2003, 23(1): 38-44.
[11] Esposito E, Iacono A, Raso GM, et al. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats[J]. Endocrinology, 2005, 146(8): 3301-3308.
[12] Baker AE, Brautigam VM, Watters JJ. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta[J]. Endocrinology, 2004, 145(11): 5021-5032.
[13] Ospina JA, Brevig HN, Krause DN, et al. Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels[J]. Am J Physiol Heart Circ Physiol, 2004, 286(5): H2010-2019.
[14] Nuedling S, Kahlert S, Loebbert K, et al. Differential effects of 17 [beta] -estradiol on mitogen- activated protein kinase pathways in rat cardiomyocytes[J]. FEBS Lett, 1999, 454(3): 271-276.
[15] Di Domenico M, Castoria G, Bilancio A, et al. Estradiol activation of human colon carcinoma- derived Caco-2 cell growth[J]. Cancer Res, 1996, 56(19): 4516-4521.
[16] Castoria G, Barone MV, Di Domenico M, et al. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis[J]. EMBO J, 1999, 18(9): 2500-2510.
[17] Jessop HL, Sjberg M, Cheng MZ, et al. Mechanical strain and estrogen activate estrogen receptor α in bone cells[J]. J Bone Miner Res, 2001, 16(6): 1045-1055.
[18] Hwang KC, Lee KH, Jang Y, et al. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells[J]. J Cardiovasc Pharmacol, 2002, 39(2): 271-277.
[19] Flores-Delgado G, Bringas P, Buckley S, et al. Nongenomic estrogen action in human lung myofibroblasts[J]. Biochem Biophys Res Commun, 2001, 283(3): 661-667.
[20] Suzuki T, Shimizu T, Yu HP, et al. 17 [beta] -estradiol administration following trauma-hemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-[alpha] [J]. Surgery, 2006, 140(2): 141-148.
[21] Geraldes P, Sirois MG, Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation[J]. Circ Res, 2003, 93(5): 399-405.
[22] Qureshi ST, Larivière L, Leveque G, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4(Tlr4)[J]. J Exp Med, 1999, 189(4): 615-625.
[23] Hsieh YC, Frink M, Thobe BM, et al. 17Beta-estradiol down-regulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma- hemorrhage[J]. Mol Immunol, 2007, 44(9): 2165-2172.
[24] Nordell VL, Lewis DK, Bake S, et al. The neurotrophin receptor p75 NTR mediates early anti- inflammatory effects of estrogen in the forebrain of young adult rats[J]. BMC Neurosci, 2005, 6: 58.
[25] Cao Z, Henzel WJ, Gao X. IRAK: a kinase associated with the interleukin-1 receptor[J]. Science, 1996, 271(5252): 1128-1131.
[26] Mamidipudi V, Li X,Wooten MW. Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-κB[J]. J Biol Chem, 2002, 277(31): 28010-28018.
[27] Kräling BM, Wiederschain DG, Boehm T, et al. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro[J]. J Cell Sci, 1999, 112(Pt 10): 1599-1609.
[28] Lee YJ, Lee EB, Kwon YE, et al. Effect of estrogen on the expression of matrix metalloproteinase(MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes[J]. Rheumatol Int, 2003, 23(6): 282-288.
[29] Nielsen RH, Christiansen C, Stolina M, et al. Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats[J]. Clin Exp Immunol, 2008, 152(1): 21-27.
[30] Campbell SE, Mehan KA, Tunstall RJ, et al. 17beta-estradiol up-regulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle[J]. J Mol Endocrinol, 2003, 31(1): 37-45.
[31] Crisafulli C, Bruscoli S, Esposito E, et al. PPAR-α contributes to the anti-inflammatory activity of 17β-estradiol[J]. J Pharmacol Exp Ther, 2009, 331(3): 796-807.
[32] Baldwin Jr AS. The NF-κB and IκB proteins: new discoveries and insights[J]. Annu Rev Immunol, 1996, 14(1): 649-681.
[33] Kalaitzidis D, Gilmore TD. Transcription factor cross-talk: the estrogen receptor and NF-[kappa] B[J]. Trends Endocrinol Metab, 2005, 16(2): 46-52.
[34] Cuzzocrea S, Mazzon E, Sautebin L, et al. The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat[J]. Mol Med, 2001, 7(7): 478-487.
[35] MacRitchie AN, Jun SS, Chen Z, et al. Estrogen up-regulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium[J]. Circ Res, 1997, 81(3): 355-362.
[36] Cvoro A, Tatomer D, Tee MK, et al. Selective estrogen receptor-beta agonists repress transcription of pro-inflammatory genes[J]. J Immunol, 2008, 180(1): 630-636.
[37] Harris HA. The unexpected science of estrogen receptor-β selective agonists: a new class of anti-inflammatory agents [J] ? Nuclear Receptor Signaling, 2006, 4: e012. |
